Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Libido
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==== Medications ==== Some people purposefully attempt to decrease their libido through the usage of [[anaphrodisiac]]s.<ref>Rebal Jr, Ronald F., Robert A. Faguet, and Sherwyn M. Woods. "Unusual sexual syndromes." ''Extraordinary Disorders of Human Behavior''. Springer US, 1982. 121-154.</ref> Aphrodisiacs, such as [[dopaminergic]] psychostimulants, are a class of drugs which can increase libido. On the other hand, a reduced libido is also often [[iatrogenic]] and can be caused by many medications, such as [[hormonal contraception]], [[selective serotonin reuptake inhibitor|SSRI]]s and other [[antidepressants]], [[antipsychotic]]s, [[opioid]]s, [[beta blocker]]s and [[isotretinoin]]. Isotretinoin, [[finasteride]] and many SSRIs uncommonly can cause a long-term decrease in libido and overall sexual function, sometimes lasting for months or years after users of these drugs have stopped taking them. These long-lasting effects have been classified as iatrogenic medical disorders, respectively termed post-retinoid sexual dysfunction/post-Accutane syndrome (PRSD/PAS), post-finasteride syndrome (PFS) and [[Selective serotonin reuptake inhibitor#Sexual dysfunction|post-SSRI sexual dysfunction (PSSD)]].<ref name=":12"/><ref name=":3">{{Cite journal|last1=Bala|first1=Areeg|last2=Nguyen|first2=Hoang Minh Tue| last3= Hellstrom|first3=Wayne J. G.| date= 2018-01-01|title=Post-SSRI Sexual Dysfunction: A Literature Review| journal=Sexual Medicine Reviews |volume=6|issue=1|pages=29–34| doi=10.1016/j.sxmr.2017.07.002|pmid=28778697|issn=2050-0521}}</ref> These three disorders share many overlapping symptoms in addition to reduced libido, and are thought to share a common etiology, but collectively remain poorly-understood and lack effective treatments. Multiple studies have shown that with the exception of [[bupropion]] (Wellbutrin), [[trazodone]] (Desyrel) and [[nefazodone]] (Serzone), antidepressants generally will lead to lowered libido.<ref name=":12" /> SSRIs that typically lead to decreased libido are [[fluoxetine]] (Prozac), [[paroxetine]] (Paxil), [[fluvoxamine]] (Luvox), [[citalopram]] (Celexa) and [[sertraline]] (Zoloft).<ref name=":12" /> Lowering the dosage of SSRI medications has been shown to improve libido in some patients.<ref name="Gonzales_1997">{{cite journal |last1=Montejo-González |first1=A L |last2=Llorca |first2=G |last3=Izquierdo |first3=J A |date=Fall 1997 |title=SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients |url=https://pubmed.ncbi.nlm.nih.gov/9292833/ |journal=J Sex Marital Ther |volume=23 |issue=3 |pages=176–194 |doi=10.1080/00926239708403923 |pmid=9292833 |access-date=2024-09-27}}</ref> Other users try enrolling in psychotherapy to solve depression-related issues of libido. However, the effectiveness of this therapy is mixed, with many reporting that it had no or little effect on sexual drive.<ref name=":12" /> [[Testosterone]] is one of the hormones controlling libido in human beings. Emerging research<ref>{{Cite journal | last1 = Warnock | first1 = J. K. | last2 = Clayton | first2 = A. | last3 = Croft | first3 = H. | last4 = Segraves | first4 = R. | last5 = Biggs | first5 = F. C. | title = Comparison of Androgens in Women with Hypoactive Sexual Desire Disorder: Those on Combined Oral Contraceptives (COCs) vs. Those not on COCs | doi = 10.1111/j.1743-6109.2006.00294.x | journal = The Journal of Sexual Medicine | volume = 3 | issue = 5 | pages = 878–882 | year = 2006 | pmid = 16942531 }}.</ref> is showing that hormonal contraception methods like oral [[contraceptive pill]]s (which rely on [[estrogen]] and [[progesterone]] together) are causing low libido in females by elevating levels of [[sex hormone-binding globulin]] (SHBG). SHBG binds to sex hormones, including testosterone, rendering them unavailable. Research is showing that even after ending a hormonal contraceptive method, SHBG levels remain elevated and no reliable data exists to predict when this phenomenon will diminish.<ref>{{Cite journal | last1 = Panzer | first1 = C. | last2 = Wise | first2 = S. | last3 = Fantini | first3 = G. | last4 = Kang | first4 = D. | last5 = Munarriz | first5 = R. | last6 = Guay | first6 = A. | last7 = Goldstein | first7 = I. | doi = 10.1111/j.1743-6109.2005.00198.x | title = Impact of Oral Contraceptives on Sex Hormone-Binding Globulin and Androgen Levels: A Retrospective Study in Women with Sexual Dysfunction | journal = The Journal of Sexual Medicine | volume = 3 | issue = 1 | pages = 104–113 | year = 2006 | pmid = 16409223 }}.</ref> [[Oral contraceptive pill|Oral contraceptives]] lower androgen levels in users, and lowered androgen levels generally lead to a decrease in sexual desire. However, usage of oral contraceptives has shown to typically not have a connection with lowered libido in women.<ref>{{Cite journal| last1=Burrows|first1=Lara J.|last2= Basha|first2=Maureen|last3=Goldstein|first3=Andrew T.|date=2012-09-01| title=The Effects of Hormonal Contraceptives on Female Sexuality: A Review|url=https://www.jsm.jsexmed.org/article/S1743-6095(15)34100-X/abstract|journal=The Journal of Sexual Medicine| language=en| volume=9|issue=9|pages=2213–2223| doi=10.1111/j.1743-6109.2012.02848.x| pmid=22788250|issn=1743-6095|url-access=subscription}}</ref><ref>{{Cite journal| last1= Davis| first1=Anne R.| last2= Castaño| first2=Paula M.|date=2004|title=Oral contraceptives and libido in women| journal=Annual Review of Sex Research|volume=15|pages=297–320| issn=1053-2528|pmid=16913282}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)